SCHEMBL6581676

SCHEMBL6581676

C=CCC(C=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AHR P35869 1/20 0.34
CYP2C19 P33261 3/20 0.34
CYP3A4 P08684 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
IDO2 Q6ZQW0 1/20 0.33
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680090 1.00 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL13965635 0.86 SLC6A4 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL8330368 0.78 ACP3 (0.38) LMNACYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL12824482 0.76 CYP3A4 (0.43) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL27925692 0.76 SLC6A3 (0.43) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL736454 0.75 HTR1A (0.42) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL10667203 0.75 SLC6A4 (0.41) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL7498979 0.75 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL10667194 0.74 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL6562184 0.73 SLC6A3 (0.39) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345899-B1 N-substituted amides as NK1 receptor antagonists ASTRAZENECA AB (SE) 2009-01-14 EP disclosed
EP-0994876-B1 QUATERNARY AMMONIUM COMPOUNDS AS TACHYKININ ANTAGONISTS PFIZER LTD (GB) 2004-09-08 EP disclosed
EP-0680962-B1 Heterocyclic compounds ASTRAZENECA AB (SE) 2003-08-20 EP disclosed
US-6380396-B1 CHEMICAL INTERMEDIATES FOR ANTIINFLAMMATORY AGENTS PFIZER INC. 2002-04-30 US disclosed
US-6207678-B1 USED FOR TREATING INFLAMMATORY DISEASE SUCH AS ARTHRITIS, PSORIASIS, ASTHMA OR INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM DISORDER SUCH AS ANXIETY, DEPRESSION, DEMENTIA OR PSYCHOSIS, GASTROINTESTINAL DISORDERS PFIZER INC 2001-03-27 US disclosed
US-5739149-A TREATING ASTHMA ZENECA LIMITED (GB) 1998-04-14 US disclosed
US-5635509-A ASTHMA; BRONCHODILATOR AGENTS; VASODILATION MICROVASCULAR PERMEABILITY; MAST CELLS ZENECA LIMITED (GB) 1997-06-03 US disclosed
EP-0680962-A2 Heterocyclic compounds ZENECA LIMITED (GB) 1995-11-08 EP disclosed